4.2 Article

Treatment of myelodysplastic syndromes with retinoic acid and 1α-hydroxy-vitamin D3 in combination with low-dose ara-C is not superior to ara-C alone. Results from a randomized study

Journal

EUROPEAN JOURNAL OF HAEMATOLOGY
Volume 45, Issue 5, Pages 255-261

Publisher

Wiley
DOI: 10.1111/j.1600-0609.1990.tb00470.x

Keywords

-

Categories

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available